您的位置: 首页 > 农业专利 > 详情页

For treating the pharmaceutical composition of the disease of cystic fibrosis transmembrane conductance regulator mediation
专利权人:
VERTEX PHARMACEUTICALS INCORPORATED
发明人:
BRIAN DEAN, PHENIX,LAURENT JEAN-CLAUDE, BAGNOL,GEOFFREY GLEN, BRODEUR,SACHIN, CHANDRAN,ELENI, DOKOU,LORI ANN, FERRIS,DRAGUTIN, KNEZIC,KATIE LYNN, MCCARTY,ALES, MEDEK,SARA A., WAGGENER,BRIAN DEAN PHENIX,LAURENT JEAN-CLAUDE BAGNOL,GEOFFREY GLEN BRODEUR,SACHIN CHANDRAN,ELENI DOKOU,LORI
申请号:
TR201809684
公开号:
TR201809684T4
申请日:
2015.04.14
申请国别(地区):
TR
年份:
2018
代理人:
摘要:
It is a feature of the present invention that the composition comprising multiple therapeutic agent, present in it, a kind of therapeutic agent can improve the characteristic of at least another kind of therapeutic agent.In one embodiment, described therapeutic agent is cystic fibrosis transmembrane conductance regulator (CFTR), such as treating disease CFTR of mediation, the CFTR correction agent of such as cystic fibrosis or CFTR synergist.Also disclose its method and medicine box.Mevcut buluş, bir terapötik maddenin varlığının en az bir başka terapötik maddenin özelliklerini geliştirdiği çok sayıda terapötik madde içeren bileşimler sunmaktadır. Bir uygulamada, terapötik maddeler, kistik fibroz gibi CFTR aracılı hastalıkların tedavisi için bir CFTR düzelticisi veya CFTR potansiyatörü gibi kistik fibrozis transmembran iletkenlik regülatörleridir (CFTR). Bunların yöntem ve kitleri de açıklanmıştır.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充